Compare Amylx Pharmaceuticals Inc (AMLX) vs Orion Office REIT Inc (ONL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Orion Office REIT Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Orion Office REIT Inc trades at $2.72 (market cap $158.01M). The key difference: Amylx Pharmaceuticals Inc is far larger — about 16.7× Orion Office REIT Inc's market cap, and Orion Office REIT Inc pays a 2.89% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | ONL | |
|---|---|---|
Market Cap | $2.64B | $158.01M |
Sector | Health | Real Estate |
52-Week High | $24.19 | $3.04 |
52-Week Low | $7.82 | $1.93 |
Enterprise Value | $2.39B | $574.95M |
Dividend Yield | — | 2.89% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Orion Office REIT Inc
Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy clients.
Read more on ONL →
